A case-control study of smoking and bladder cancer risk: Emergent patterns over time

Journal of the National Cancer Institute

Volumn 101, Issue 22, 2009, Pages 1553-1561

  Baris, Dalsu ^a   Karagas, Margaret R ^b   Verrill, Castine ^d   Johnson, Alison ^f   Andrew, Angeline S ^b   Marsit, Carmen J ^c   Schwenn, Molly ^d   Colt, Joanne S ^a   Cherala, Sai ^a   Samanic, Claudine ^e   Waddell, Richard ^b   Cantor, Kenneth P ^a   Schned, Alan ^b   Rothman, Nathaniel ^a   Lubin, Jay ^a   Fraumeni, Joseph F ^a   Hoover, Robert N ^a   Kelsey, Karl T ^c   Silverman, Debra T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c BROWN UNIVERSITY   (United States)

^d Maine Cancer Registry   (United States)

^e New Hampshire Cancer Registry   (United States)

^f Vermont Cancer Registry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING CESSATION; UNITED STATES; UROGENITAL TRACT CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MAINE; MALE; MIDDLE AGED; NEW HAMPSHIRE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; URINARY BLADDER NEOPLASMS; VERMONT;

EID: 72949120222     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp361     Document Type: Article

References (48)

1. Silverman DT, Devesa SS, Moore LL, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press ; 2006: 1101-1127.
2. Jones PA, Ross RK. Prevention of bladder cancer. N Engl J Med. 1999 ; 340 (18): 1424-1426.
3. Stabbert R, Schafer KH, Biefel C, et al. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom. 2003 ; 17 (18): 2125-2132.
4. Riedel K, Scherer G, Engl J, et al. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol. 2006 ; 30 (3): 187-195.
5. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specifi c N-nitrosamines. Chem Res Toxicol. 1998 ; 11 (6): 559-603.
6. Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control. 1997 ; 8 (3): 346-355.
7. Skipper PL, Tannenbaum SR, Ross RK, et al. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2003 ; 12 (6): 503-507.
8. Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev. 2006 ; 15 (7): 1348-1354.
9. Vineis P, Kogevinas M, Simonato L, et al. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res. 2000 ; 463 (1): 103-110.
10. Hartge P, Silverman D, Hoover R, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst. 1987 ; 78 (6): 1119-1125. (Pubitemid 17113643)
11. Castelao JE, Yuan JM, Skipper PL, et al. Gender-and smoking-related bladder cancer risk. J Natl Cancer Inst. 2001 ; 93 (7): 538-545.
12. Sorahan T, Lancashire RJ, Sole G. Urothelial cancer and cigarette smoking: fi ndings from a regional case-controlled study. Br J Urol. 1994 ; 74 (6): 753-756.
13. Jiang X, Yuan JM, Skipper PL, et al. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res. 2007 ; 67 (15): 7540-7545.
14. Alberg AJ, Kouzis A, Genkinger JM, et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol. 2007 ; 165 (6): 660-666.
15. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2006 ; 17 (10): 1305-1309.
16. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control. 2002 ; 13 (1): 83-90.
17. Kabat GC, Dieck GS, Wynder EL. Bladder cancer in nonsmokers. Cancer. 1986 ; 57 (2): 362-367.
18. Hoffmann D, Hoffmann I. The changing cigarettes: chemical studies and bioassays. In: Shopland DR, Burns DM, Benowitz NL, Amacher RH, eds. Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: U.S. NIH, National Cancer Institute, NIH Publication No. 02-5074; 2001:159-219
19. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med. 1997 ; 26 (4): 427-434.
20. Hoffmann D, Hoffmann I, El Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol. 2001 ;14 (7): 767-790.
21. Lubin JH, Alavanja MC, Caporaso N, et al. Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol. 2007 ; 166 (4): 479-489.
22. Lubin JH, Caporaso NE. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 2006 ;15(3): 517-523.
23. Karagas MR, Tosteson TD, Morris JS, et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 2004 ; 15 (5): 465-472.
24. Fortuny J, Kogevinas M, Zens MS, et al. Analgesic and anti-infl ammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol. 2007 ; 7 (13).
25. Peppone LJ, Hayland A, O'Connor JO. Cigarette smoking, bladder cancer and change in risk over 40 years. In: Frontiers in Cancer Prevention Research Conference Proceedings ; November 12-15, 2006; Boston, MA.
26. Patrianakos C, Hoffmann D. Chemical studies on tobacco smoke LXIV. On the analyses of aromatic amines in cigarettes smoke. J Anal Toxicol. 1979 ; 3 (4): 150-154.
27. Masuda Y, Hoffmann D. Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke. Anal Chem. 1969 ; 41 (4): 650-652.
28. Benowitz NL. Compensatory smoking of low yields cigarettes. In: Shopland DR, Burns DM, Benowitz NL, Amacher RH, eds. Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: U.S. NIH, National Cancer Institute, NIH Publication No. 02-5074, 2001:39-63.
29. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl). 1999 ; 145 (1): 1-20.
30. Brooks DR, Austin JH, Heelan RT, et al. Infl uence of type of cigarette on peripheral versus central lung cancer. Cancer Epidemiol Biomarkers Prev. 2005 ; 14 (3): 576-581.
31. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005 ; 117 (2): 294-299.
32. Jemal A, Travis WD, Tarone RE, et al. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer. 2003 ; 105 (1): 101-107.
33. Wynder EL, Hoffmann D. Re: Cigarette smoking and the histopathology of lung cancer. J Natl Cancer Inst. 1998 ; 90 (19): 1486-1488.
34. Stellman SD, Muscat JE, Thompson S, et al. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime fi lter cigarette smoking. Cancer. 1997 ; 80 (3): 382-388.
35. Burns DM, Major JM, Shanks TG, Thun MJ, Samet JM. Smoking lower yield cigarettes and disease risk. In: Shopland DR, Burns DM, Benowitz NL, Amacher RH, eds. Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: U.S. NIH, National Cancer Institute, NIH Publication No. 02-5074; 2001:65-158.
36. Decarli A, Peto J, Piolatto G, et al. Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. Br J Cancer. 1985 ; 51 (5): 707-712.
37. Lubin JH, Virtamo J, Weinstein SJ, et al. Cigarette smoking and cancer: intensity patterns in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finnish men. Am J Epidemiol. 2008 ; 167 (8): 970-975.
38. Lubin JH, Kogevinas M, Silverman D, et al. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int J Epidemiol. 2007 ; 36 (1): 236-241.
39. Sak SC, Barrett JH, Paul AB, et al. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet. 2007 ; 8 (13).
40. Vineis P, Marinelli D, Autrup H, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev. 2001 ; 10 (12): 1249-1252.
41. Law MR, Morris JK, Watt HC, et al. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer. 1997 ; 75 (11): 1690-1693.
42. Lubin JH, Caporaso N, Wichmann HE, et al. Cigarette smoking and lung cancer: modeling effect modifi cation of total exposure and intensity. Epidemiology. 2007 ; 18 (5): 639-648. (Pubitemid 47263041)
43. Day NE, Brown CC. Multistage models and primary prevention of cancer. J Natl Cancer Inst. 1980 ; 64 (4): 977-989.
44. Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer. 2000 ; 86 (2): 289-294.
45. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M, et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2006 ; 119 (10): 2412-2416. (Pubitemid 44546965)
46. Zeegers MP, Kellen E, Buntinx F, et al. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004 ; 21 (6): 392-401.
47. Burch JD, Rohan TE, Howe GR, et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer. 1989 ; 44 (4): 622-628.
48. Van Hemelrijck MJ, Michaud DS, Connolly GN, et al. Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses. Cancer Epidemiol Biomarkers Prev. 2009 ; 18 (4): 1312-1320